Nancy Chan
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 28
- Cancer Immunotherapy and Biomarkers 8
- HER2/EGFR in Cancer Research 7
- Cancer Treatment and Pharmacology 7
- PARP inhibition in cancer therapy 6
- Lung Cancer Research Studies 4
-
- Advanced Breast Cancer Therapies 7
- Co-authors
- Shridar Ganesan (9 shared papers)Zia A. Khan (3 shared papers)Jyoti Malhotra (12 shared papers)Eugenia Girda (5 shared papers)Alexandra Kleiman (2 shared papers)Ann W. Silk (10 shared papers)Salma K. Jabbour (3 shared papers)Aliza Leiser (2 shared papers)
- Journals
- Journal of Clinical Oncology (14 papers)Cancer Research (8 papers)Clinical Cancer Research (3 papers)Experimental and Molecular Pathology (2 papers)Anticancer Research (1 paper)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Nancy Chan
50 papers receiving 900 citations
Nancy Chan's Hit Papers
Peers
Comparison fields: 5 of 79
- Oncology 312
- Cancer Research 106
- Pulmonary and Respiratory Medicine 185
- Surgery 188
- Pathology and Forensic Medicine 71
Countries citing papers authored by Nancy Chan
This map shows the geographic impact of Nancy Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Chan more than expected).
Fields of papers citing papers by Nancy Chan
This network shows the impact of papers produced by Nancy Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Chan. The network helps show where Nancy Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Nancy Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers Hit paper breakdown → | 2021 | 214 |
| 2 | 2019 | 189 | |
| 3 | 2017 | 41 | |
| 4 | 2012 | 33 | |
| 5 | 2013 | 27 | |
| 6 | 2022 | 24 | |
| 7 | 1999 | 24 | |
| 8 | Pathological reporting of colorectal cancer specimens: a retrospective survey in an academic Canadian pathology department. | 2008 | 22 |
| 9 | 2012 | 21 | |
| 10 | 2017 | 20 | |
| 11 | 2012 | 20 | |
| 12 | 2013 | 19 | |
| 13 | 2018 | 19 | |
| 14 | 1995 | 19 | |
| 15 | 2020 | 18 | |
| 16 | 2020 | 15 | |
| 17 | 2022 | 14 | |
| 18 | 2022 | 13 | |
| 19 | 2016 | 13 | |
| 20 | 2018 | 13 |
About Nancy Chan
Nancy Chan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Surgery, having authored 58 papers that have together received 912 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), HER2/EGFR in Cancer Research (7 papers), Cancer Treatment and Pharmacology (7 papers), Advanced Breast Cancer Therapies (7 papers), PARP inhibition in cancer therapy (6 papers), Cancer, Hypoxia, and Metabolism (5 papers), Lung Cancer Research Studies (4 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Oncology (312 citations), Cancer Research (106 citations), Pulmonary and Respiratory Medicine (185 citations), Surgery (188 citations) and Pathology and Forensic Medicine (71 citations). Nancy Chan has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Shridar Ganesan, Zia A. Khan, Jyoti Malhotra, Eugenia Girda, Alexandra Kleiman, Ann W. Silk, Salma K. Jabbour, Aliza Leiser, Alexandre Buckley de Meritens and Gregory Riedlinger. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, Experimental and Molecular Pathology and Anticancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.